Arkray's Glucocard Vital gets FDA OK
This article was originally published in Clinica
The US FDA has granted 510(k) clearance for Arkray's Glucocard Vital blood glucose monitoring system. The Japanese diagnostics firm will start distributing the device in early December. The meter and strip platform will be "ideal" for the home medical equipment, durable medical equipment, mail order and managed care markets, Arkray believes. The new addition to the Glucocard brand requires only 0.5 microlitres of blood and holds 250 downloadable tests in its memory.